HLA-B51 Genotyping for Behçet’s Disease
Behçet’s Disease is a rare disorder that causes inflammation in blood vessels throughout the body. The inflammation of Behcet's disease leads to numerous symptoms that may initially seem unrelated and frequently include oral mucocutaneous ulcerations, uveitis, abdominal discomfort, cough and fever.
Behçet’s disease is most common in Mediterranean countries, the Middle East, Japan and other parts of Asia. However, it has been found in populations worldwide. The highest prevalence of Behçet disease has been reported in Turkey, where the disorder affects up to 420 in 100,000 people. The disorder is much less common in northern European countries and the United States, where it generally affects fewer than 1 in 100,000 people.
Several alleles of HLA-B51 (B*5101, B*5108, B*5105, and B*5104) are strongly associated with Behçet’s Disease, particularly in cases with eye involvement. Furthermore, patients who were HLA-B51 homozygous demonstrated a considerably higher risk for disease indicating a possible gene-dose effect. The exact contribution of HLA-B51 to the development of Behçet’s Disease is unclear. Another gene, the SUMO4 + 438 C allele, is associated with susceptibility to BD in HLA-B51 negative patients.
- Risk assessment for Behçet’s Disease
- Supportive diagnosis of Behçet’s Disease
Negative for HLA-B51 variation
Whole blood (ACD yellow top tube is preferred, EDTA lavender top tube also accepted).
Stability
- Ambient: 5 days
- Refrigerated: 7 days
- Rheumatology. 2012;51(5):887-900. [PMID: 22240504]
- Arthritis Rheum. 2009;61(10):1287-96. [PMID: 19790126]
- Arthritis Rheum. 2005;52(6):1836–42. [PMID: 15934084]
- Eye. 2008;23(5):1182–6. [PMID: 18551141]
- Rheumatology (Oxford). 2012 May;51(5):887-900. [PMID: 22240504]